Prevalence and distribution of human papillomavirus types in cervical cancer, squamous intraepithelial lesions, and with no intraepithelial lesions in women from Southern Mexico

Gynecologic Oncology

Volumn 117, Issue 2, 2010, Pages 291-296

  Illades Aguiar, Berenice ^a   Alarcón Romero, Luz del Carmen ^a   Antonio Véjar, Verónica ^a   Zamudio López, Noelio ^a   Sales Linares, Natividad ^a   Flores Alfaro, Eugenia ^a   Fernández Tilapa, Gloria ^a   Vences Velázquez, Amalia ^a   Muñoz Valle, José Francisco ^b   Leyva Vázquez, Marco Antonio ^a  

^a UNIVERSIDAD AUTÓNOMA DE GUERRERO   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Cervical cancer; Cervical cancer in Mexico; Human papillomavirus; Human papillomavirus epidemiology in Mexico; Human papillomavirus genotypes in Mexico

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOLOGY; DNA SEQUENCE; FEMALE; GENOTYPE; GYNECOLOGIC DISEASE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEXICO; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CERVICAL INTRAEPITHELIAL NEOPLASIA; CROSS-SECTIONAL STUDIES; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MEXICO; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 77950187578     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.01.036     Document Type: Article

References (39)

1. Palacio-Mejía L.S., Rangel-Gómez G., Hernández-Avila M., and Lazcano-Ponce E. Cervical cancer, a disease of poverty: mortality differences between urban and rural areas in Mexico. Salud Publica Mex. 45 (2003) S315-S325
2. Secretaría de Salud. Dirección General de Información en Salud. Mexico, 2006. Available from URL: http://sinais.salud.gob.mx/. Accessed March 27, 2009.
3. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19
4. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., and zurHausen H. Classification of papillomaviruses. Virol 324 (2004) 17-27
5. Muñoz N., Castellsagué X., Berrington de González A., and Gissmann L. HPV in the etiology of human cancer. Vaccine (2006) 24S3:S3/1-10
6. Clifford G.M., Smith J.S., Plummer M., Muñoz N., and Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J. Cancer 88 (2003) 63-73
7. Berumen J., Ordoñez R.M., Lazcano E., Salmerón J., Galván S.C., Estrada R.A., et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J. Natl. Cancer Inst. 93 (2001) 1325-1330
8. Zehbe I., Wilander E., Delius H., and Tommasino M. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 58 (1998) 829-833
9. Herrero R., Hildesheim A., Bratti C., Sherman M.E., Hutchinson M., Morales J., et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J. Natl. Cancer Inst. 92 (2000) 464-474
10. Wright T.C., and Kurman R.J. A critical review of the morphologic classification systems of preinvasive lesions of the cervix: the scientific basis for shifting the paradigm. Papillomavirus Rep. 5 (1994) 175-182
11. Clifford G.M., Gallus S., Herrero R., Muñoz N., Snijders P.J.F., Vaccarella S., et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366 (2005) 991-998
12. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287 (2002) 2114-2119
13. FIGO Committee on Gynecologic Oncology. Staging classifications and clinical practice guidelines of gynaecologic cancers. Int. J. Gynecol. Obstet. 70 (2000) 207-312
14. Leonard D., Michael K., and James B. Basic Methods in Molecular Biology (1994), Appleton & Lange, Connecticut
15. Bauer H.M., Greer C.E., and Manos M.M. Determination of genital human papillomavirus infection by consensus PCR amplification. In: Herrington C.S., and McGee J.O. (Eds). Diagnostic Molecular Pathology: A Practical Approach (1992), Oxford University Press, Oxford 131-152
16. Bauer H.M., and Manos M.M. PCR detection of genital human papillomavirus. In: Persing D.H., Smith T.F., Tenover F.C., and White T.J. (Eds). Diagnostic Molecular Microbiology, Principles and Applications (1993), American Society for Microbiology, Washington 407-413
17. Vossler J.L., Forbes B.A., and Adelson M.D. Evaluation of the polymerase chain reaction for the detection of human papillomavirus from urine. J. Med. Virol. 45 (1995) 354-360
18. Bernard H.U., Chan S.Y., Manos M.M., Ong C.K., Villa L.L., Delius H., et al. Identification and assessment of known and novel human papillomavirus by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J. Infect. Dis. 170 (1994) 1077-1085
19. de Roda Husman A.M., Walboomers J.M., van den Brule A.J., Meijer C.J., and Snijders P.J. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J. Gen. Virol. 76 (1995) 1057-1062
20. National Center for Biotechnology Information. U.S. National Library of Medicine. Bethesda, MD. Available from URL: http://www.ncbi.nlm.nih.gov/BLAST/. Accessed: May 8, 2007.
21. Casas L., Galván S.C., Ordoñez R.M., López N., Guido M., and Berumen J. Asian-american variants of human papillomavirus type 16 have extensive mutations in the E2 gene and are highly amplified in cervical carcinomas. Int. J. Cancer 83 (1999) 449-455
22. Yamada T., Manos M.M., Peto J., Greer C., Muñoz N., Bosh F.X., et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J. Virol. 71 (1997) 2463-2472
23. Muñoz N., Bosch F.X., Castellsagué X., Díaz M., de Sanjosé S., Hammouda D., et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int. J. Cancer 111 (2004) 278-285
24. Torroella-Kouri M., Morsberger S., Carrillo A., Mohar A., Meneses A., Ibarra M., et al. HPV prevalence among Mexican women with neoplastic and normal cervixes. Gynecol. Oncol. 70 (1998) 115-120
25. González-Losa M.R., Rosado-López I., Valdez-González N., and Puerto-Solís M. High prevalence of human papillomavirus type 58 in Mexican colposcopy patients. J. Clin. Virol. 29 (2004) 202-205
26. Tirado-Gómez L.L., Mohar-Betancourt A., López-Cervantes M., García-Carrancá A., Franco-Marina F., and Borges G. Risk factors in invasive cervical cancer among Mexican women. Salud Pública Mex. 47 (2005) 342-350
27. Poljak M., Fujs K., Seme K., Kocjan B.J., and Vrtacnik-Bokal E. Retrospective and prospective evaluation of the amplicor HPV test for detection of 13 high-risk human papillomavirus genotypes on 862 clinical samples. Acta Dermatoven. APA 14 (2005) 147-152
28. Clifford G.M., Smith J.S., Aguado T., and Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br. J. Cancer. 89 (2003) 101-105
29. López-Revilla R., Martínez-Contreras L.A., and Sánchez-Garza M. Prevalence of high-risk human papillomavirus types in Mexican women with cervical neoplasia and invasive carcinoma. Infect. Agent Cancer 3 (2008) 3
30. Clifford G.M., Rana R.K., Franceschi S., Smith J.S., Gough G., and Pimenta J.M. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 1157-1164
31. Lazcano-Ponce E., Herrero R., Muñoz N., Cruz A., Shah K.V., Alonso P., et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int. J. Cancer 91 (2001) 412-420
32. Giuliano A.R., Papenfuss M., Abrahamsen M., Denman C., Guernsey de Zapien J., Navarro-Henze J.L., et al. Human papillomavirus infection at the United States-Mexico border: implicatins for cervical cancer Prevention and control. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 1129-1136
33. Burk R.D., Kelly P., Feldman J., Bromberg J., Vermund S.H., DeHovitz J.A., et al. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex. Transm. Dis. 23 (1996) 333-341
34. Peto J., Gilham C., Deacon J., Taylor C., Evans C., Binns W., et al. Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br. J. Cancer 91 (2004) 942-953
35. Kjaer S.K., van den Brule A.J.C., Bock J.E., Poll P.A., Engholm G., Sherman M.E., et al. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types?. Cancer Epidemiol. Biomarkers Prev. 6 (1997) 799-805
36. Franceschi S., Herrero R., Clifford G.M., Snijders P.J.F., Arslan A., Anh P.T.H., et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int. J. Cancer 119 (2006) 2677-2684
37. Kulmala S.M.A., Shabalova I.P., Petrovitchev N., Syrjänen K.J., Gyllensten U.B., and Syrjänen S.M. Prevalence of the most common high-risk genotypes among women in three new independent states o the Former Soviet Union. J. Med. Virol. 79 (2007) 771-781
38. Lizano M., De la Cruz-Hernández E., Carrillo-García A., García-Carrancá A., Ponce de Léon-Rosales S., Dueñas González A., et al. Distribution of HPV 16 and 18 intratypic variants in normal cytology, inraepithelial lesions, and cervical cancer in a Mexican population. Gynecol. Oncol. 102 (2006) 230-235
39. Kammer C., Warthorst U., Torrez-Martínez N., Wheeler C.M., and Pfister H. Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. J. Gen. Virol. 81 Pt8 (2000) 1975-1981